ArticleBiotechnology and bioengineering2026
Characterizing Spatiotemporal Expansion of Pseudomonas aeruginosa Communities in Polymer and Mucin Gel Environments.
Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing Spatiotemporal Expansion of Pseudomonas aeruginosa Communities in Polymer and Mucin Gel Environments.Biotechnology and bioengineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Opportunistic colonization and recurring infection by Pseudomonas aeruginosa are substantial risks to lung functionality for people with underlying respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease. The complex metabolic and phenotypic adaptations P. aeruginosa exhibits in response to its environmental conditions make relevant in vitro models of pathogenic populations crucial for identifying and evaluating effective antimicrobial targets. However, an extracellular component that is rarely integrated into these experimental platforms is a spatially extensive, semisolid gel medium representative of biological respiratory mucus layers that P. aeruginosa propagates through via active motility. In this investigation, we examine the applicability of swim plate assays, a qualitative methodology for measuring flagellar swimming motility, as an in vitro platform to study the spatiotemporal development of P. aeruginosa strain PA14. The propagation behavior of PA14 was tracked through time-lapse microscopy and studied under different agar gel compositions incorporating methylcellulose as well as native MUC5AC mucin. To aid quantitative characterization of PA14 population expansion, we paired this experimental workflow with a continuum model that would fit density profile fluctuations to changes in PA14 swimming motility and growth kinetics. We observed higher extracellular concentration and production of the phenazine pyocyanin when PA14 populations were grown in swim plate assays, supporting the emergence of heterogeneous growth environments within the microbial population. PA14 swim plates exhibited a significantly lower spreading velocity in gels containing 0.30% w/v MUC5AC, which model-to-experiment fitting results determined to be driven by reductions in PA14 swimming motility. Continuum model parameters additionally portrayed PA14 expansion in mucin gels, having cell growth outcompeting cell motility, which aligned with experimental assay observations of macrocolonies rapidly developing to high biomass density states. In contrast, PA14 did not show spreading velocity differences in gels containing 0.30% methylcellulose, and fitted parameters did not identify major growth and motility differences when compared to agar-only gels. Combined with the resource accessibility of this experimental platform, the swim plate assay as an in vitro model is well suited to investigations of pathogenic community dynamics in gel conditions over more extensive spatial and time scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.